Short answer
Design Therapeutics, Inc. (DSGN) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Simeon George, M.D. elected Class II director through 2029 annual meeting.
Design Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Simeon George, M.D. elected Class II director through 2029 annual meeting
- Director vote: 29,205,208 for, 7,608,724 withheld, 13,264,883 broker non-votes
- Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Auditor ratification received 50,077,708 for, 201 against and 906 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Design Therapeutics, Inc. 8-K filings
Get the next DSGN 8-K as it lands
Follow DSGN for push alerts, or ask the research agent what this filing means.